Thomas E Fuller-Rowell1, David S Curtis2, Mona El-Sheikh2, David H Chae2, Jennifer Morozink Boylan3, Carol D Ryff4. 1. Department of Human Development and Family Studies, Auburn University, AL, USA. Electronic address: tom.fullerrowell@gmail.com. 2. Department of Human Development and Family Studies, Auburn University, AL, USA. 3. Department of Health and Behavioral Sciences, University of Colorado Denver, USA. 4. Department of Psychology, University of Wisconsin - Madison, WI, USA.
Abstract
OBJECTIVE: Disparities in sleep duration and efficiency between Black/African American (AA) and White/European American (EA) adults are well-documented. The objective of this study was to examine neighborhood disadvantage as an explanation for race differences in objectively measured sleep. METHODS: Data were from 133 AA and 293 EA adults who participated in the sleep assessment protocol of the Midlife in the United States (MIDUS) study (57% female; Mean Age = 56.8 years, SD = 11.4). Sleep minutes, onset latency, and waking after sleep onset (WASO) were assessed over seven nights using wrist actigraphy. Neighborhood characteristics were assessed by linking home addresses to tract-level socioeconomic data from the 2000 US Census. Multilevel models estimated associations between neighborhood disadvantage and sleep, and the degree to which neighborhood disadvantage mediated race differences in sleep controlling for family socioeconomic position and demographic variables. RESULTS: AAs had shorter sleep duration, greater onset latency, and higher WASO than EAs (ps < 0.001). Neighborhood disadvantage was significantly associated with WASO (B = 3.54, p = 0.028), but not sleep minutes (B = -2.21, p = 0.60) or latency (B = 1.55, p = 0.38). Furthermore, race was indirectly associated with WASO via neighborhood disadvantage (B = 4.63, p = 0.035), which explained 24% of the race difference. When measures of depression, health behaviors, and obesity were added to the model, the association between neighborhood disadvantage and WASO was attenuated by 11% but remained significant. CONCLUSION: Findings suggest that neighborhood disadvantage mediates a portion of race differences in WASO, an important indicator of sleep efficiency.
OBJECTIVE: Disparities in sleep duration and efficiency between Black/African American (AA) and White/European American (EA) adults are well-documented. The objective of this study was to examine neighborhood disadvantage as an explanation for race differences in objectively measured sleep. METHODS: Data were from 133 AA and 293 EA adults who participated in the sleep assessment protocol of the Midlife in the United States (MIDUS) study (57% female; Mean Age = 56.8 years, SD = 11.4). Sleep minutes, onset latency, and waking after sleep onset (WASO) were assessed over seven nights using wrist actigraphy. Neighborhood characteristics were assessed by linking home addresses to tract-level socioeconomic data from the 2000 US Census. Multilevel models estimated associations between neighborhood disadvantage and sleep, and the degree to which neighborhood disadvantage mediated race differences in sleep controlling for family socioeconomic position and demographic variables. RESULTS: AAs had shorter sleep duration, greater onset latency, and higher WASO than EAs (ps < 0.001). Neighborhood disadvantage was significantly associated with WASO (B = 3.54, p = 0.028), but not sleep minutes (B = -2.21, p = 0.60) or latency (B = 1.55, p = 0.38). Furthermore, race was indirectly associated with WASO via neighborhood disadvantage (B = 4.63, p = 0.035), which explained 24% of the race difference. When measures of depression, health behaviors, and obesity were added to the model, the association between neighborhood disadvantage and WASO was attenuated by 11% but remained significant. CONCLUSION: Findings suggest that neighborhood disadvantage mediates a portion of race differences in WASO, an important indicator of sleep efficiency.
Authors: A V Diez-Roux; C I Kiefe; D R Jacobs; M Haan; S A Jackson; F J Nieto; C C Paton; R Schulz; A V Roux Journal: Ann Epidemiol Date: 2001-08 Impact factor: 3.797
Authors: Jens Ludwig; Lisa Sanbonmatsu; Lisa Gennetian; Emma Adam; Greg J Duncan; Lawrence F Katz; Ronald C Kessler; Jeffrey R Kling; Stacy Tessler Lindau; Robert C Whitaker; Thomas W McDade Journal: N Engl J Med Date: 2011-10-20 Impact factor: 91.245
Authors: Natalie Slopen; Lauren M Dutra; David R Williams; Mahasin S Mujahid; Tené T Lewis; Gary G Bennett; Carol D Ryff; Michelle A Albert Journal: Nicotine Tob Res Date: 2012-02-24 Impact factor: 4.244
Authors: Michael Littner; Clete A Kushida; W McDowell Anderson; Dennis Bailey; Richard B Berry; David G Davila; Max Hirshkowitz; Sheldon Kapen; Milton Kramer; Daniel Loube; Merrill Wise; Stephen F Johnson Journal: Sleep Date: 2003-05-01 Impact factor: 5.849
Authors: Lauren B Covington; Valerie E Rogers; Bridget Armstrong; Carla L Storr; Maureen M Black Journal: J Clin Sleep Med Date: 2019-06-15 Impact factor: 4.062
Authors: Rebecca E Rottapel; Eric S Zhou; Christine E Spadola; Cheryl R Clark; Emily Z Kontos; Kadona Laver; Jarvis T Chen; Susan Redline; Suzanne M Bertisch Journal: Sleep Health Date: 2020-01-23
Authors: Tao Liang; Heather M Munro; Margaret K Hargreaves; Mark D Steinwandel; William J Blot; Maciej S Buchowski Journal: Sleep Med Date: 2020-09-10 Impact factor: 3.492
Authors: David S Curtis; Thomas E Fuller-Rowell; Mona El-Sheikh; Mercedes R Carnethon; Carol D Ryff Journal: Proc Natl Acad Sci U S A Date: 2017-07-31 Impact factor: 11.205
Authors: Jaimie C Hunter; Elizabeth P Handing; Ramon Casanova; Maragatha Kuchibhatla; Michael W Lutz; Santiago Saldana; Brenda L Plassman; Kathleen M Hayden Journal: Alzheimers Dement Date: 2018-02-01 Impact factor: 21.566
Authors: Thomas E Fuller-Rowell; Lydia K Homandberg; David S Curtis; Vera K Tsenkova; David R Williams; Carol D Ryff Journal: Psychoneuroendocrinology Date: 2019-04-29 Impact factor: 4.905